| 中文名 | 6,7,8-三氟-1-(甲酰基甲基氨基)-4-氧代-1,4-二氢喹啉-3-甲酸乙酯 |
|---|---|
| 英文名 | 6,7,8-Trifluor-1-(formylmethylamino)-1,4-dihydro-4-oxo-3-chinolincarbonsaeure-ethylester |
| 中文别名 |
6,7,8-三氟-1-(甲酰基甲基氨基)-1,4-二氢-4-氧代-3-喹啉羧酸乙酯
6,7,8-三氟-1-(甲酰基甲基氨基)-4-氧代-1,4-二氢喹啉-3-甲酸乙酯/100-1 6,7,8-三氟-1-(甲酰基甲基氨基)-4-氧代-1,4-二氢喹啉-3-甲酸乙酯/6,7,8-TRIFLUOR-1-(FORMYLMETHYLAMINO)-1,4-DIHYDRO-4-OXO-3-CHINOLINCBONSAEURE-ETHYLESTER |
| 英文别名 |
ethyl 6,7,8-trifluoro-1,4-dihydro-1-(N-methyl-formamido)-4-oxo-3-quinolinecarboxylate
6,7,8-Trifluoro-1-(formylmethylamino)-1,4-dihydro-4-oxo-3-quinolinecboxylic acid ethyl ester ethyl 6,7,8-trifluoro-1-(formylmethylamino)-1,4-dihydro-4-oxo-3-quinolinecarboxylate 6,7,8-Trifluoro-1- (formylmethylamino) -4-oxo-1,4-dihydroquinoline-3-cboxylic acid ethyl ester ethyl 6,7,8-trifluoro-1-[formyl(methyl)amino]-4-oxo-1,4-dihy Ethyl 6,7,8-trifluoro-1-(formylmethylamino)-1,4-dihydro-4-oxo-3-quinolinecboxylate Intermediate of Mabofloxacin 6,7,8-Trifluo-1-(formylmethylamino)-1,4-dihydro-4-oxo-3-quinolinecboxylicacid ethylester 6,7,8-Trifluor-1-(formylmethylamino)-1,4-dihydro-4-oxo-3-chinolincbonsaeure-ethylester 6,7,8-trifluoro-1-(Formylmethylamino)-4-Oxo-1,4-Dihydroquinoline-3-Ethyl formate 6,7,8-trifluoro-1-(N-methylformamido)-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid ethyl ester 3-Quinolinecboxylic acid, 6,7,8-trifluoro-1-(formylmethylamino)-1,4-dihydro-4-oxo-, ethyl ester |
| 分子式 | C14H11F3N2O4 |
|---|---|
| 分子量 | 328.24300 |
| 精确质量 | 328.06700 |
| PSA | 68.61000 |
| LogP | 1.95560 |
| 储存条件 | 室温, 密封, 干燥 |
| 危害码 (欧洲) | Xn |
|---|
|
~%
100276-65-1 |
| 文献:Pfizer. Inc Patent: US5892040 A1, 1999 ; |
|
~86%
100276-65-1 |
| 文献:Grohe, Klaus; Heitzer, Helmut Liebigs Annalen der Chemie, 1987 , p. 871 - 880 |
| 上游产品 2 | |
|---|---|
| 下游产品 1 | |